For all class III devices and for the class IIb devices referred to in point (b) of Article 54(1), the manufacturer may, prior to its clinical evaluation and/or investigation, consult an expert panel as referred to in Article 106, with the aim of reviewing the manufacturer's intended clinical development strategy and proposals for clinical investigation.
I gcás na bhfeistí uile in aicme III agus i gcás feistí in aicme IIb dá dtagraítear i bpointe (b) d'Airteagal 54(1), féadfaidh an monaróir, roimh mheastóireacht chliniciúil agus/nó imscrúdú ar an bhfeiste, dul i gcomhairle le painéal saineolaithe amhail dá dtagraítear in Airteagal 106, agus é mar aidhm straitéis bheartaithe forbartha an mhonaróra agus a thograí le haghaidh imscrúdú cliniciúil a athbhreithniú agus a mheas.